# A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)

> **NCT00234104** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 122 (actual)

## Conditions studied

- Heart Failure, Congestive
- Edema

## Interventions

- **DRUG:** OPC-41061(Tolvaptan)

## Key facts

- **NCT ID:** NCT00234104
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2013-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234104, "A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00234104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*